Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
LQWD Technologies Lightning Network Infrastructure Surpasses 1 Million Global Transactions (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum MedMira Inc V.MIR

Alternate Symbol(s):  MMIRF

Healthcare Medical Devices
MedMira Inc. is a Canada-based developer and manufacturer of Rapid Vertical Flow (RVF) diagnostics. The Company's tests provide hospitals, labs, clinics and individuals with instant disease diagnosis, such as human immunodeficiency virus (HIV), syphilis, hepatitis, and SARS-CoV-2, in three steps. The Company is engaged in the business of research, development and manufacturing of rapid... see more

TSXV:MIR - Post Discussion

MedMira Inc > What's this all about ? DIACARTA
View:
Post by reyesingup on Apr 27, 2023 2:02pm

What's this all about ? DIACARTA

Logo
 
 
 
 
 
 
 
Introducing DiaCarta Clinical Laboratory's comprehensive Lab Developed Test (LDT) designed to accurately identify and differentiate between SARS-CoV-2, Influenza A/B, and Respiratory Syncytial Virus (RSV) with qRT-PCR.
 
 
 
DiaCarta’s SARS-CoV-2 qPCR Test (FDA EUA) targets all the relevant genes and picks up the new emerging variants providing:
Lorem ipsum CLIA Certified
 
Ensuring top-quality testing standards

Rapid Results
 
24-48 hours turnaround time

Nasal Samples
 
Non-invasive and comfortable collection 

Cost-Effective
 
Covered by most insurance 
 
 
 
Lorem ipsum CLIA Certified
 
Ensuring top-quality testing standards
Rapid Results
 
24-48 hours turnaround time
 
 
 
Nasal Samples
 
Non-invasive and comfortable collection 
Cost-Effective
 
Covered by most insurance 
 
 
 
Contact us today and let us know what targets of mutations you would like to have.
 
 
 
 
Email: order@diacarta.com
 
DOWNLOAD NOW
 
 
 
 
 
 
 
 
 
Changed your mind? You can Unsubscribe here at any time
 
 
Be the first to comment on this post
MedMira Inc
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Dealroom for high-potential pre-IPO opportunities